APA

Cordelier P., Kulkowsky J. W., Ko C., Matskevitch A. A., McKee H. J., Rossi J. J., Bouhamdan M., Pomerantz R. J., Kari G. & Strayer D. S. (20050202). Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. : Gene therapy.

Chicago

Cordelier P, Kulkowsky J W, Ko C, Matskevitch A A, McKee H J, Rossi J J, Bouhamdan M, Pomerantz R J, Kari G and Strayer D S. 20050202. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. : Gene therapy.

Harvard

Cordelier P., Kulkowsky J. W., Ko C., Matskevitch A. A., McKee H. J., Rossi J. J., Bouhamdan M., Pomerantz R. J., Kari G. and Strayer D. S. (20050202). Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. : Gene therapy.

MLA

Cordelier P, Kulkowsky J W, Ko C, Matskevitch A A, McKee H J, Rossi J J, Bouhamdan M, Pomerantz R J, Kari G and Strayer D S. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. : Gene therapy. 20050202.